Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Dellapasqua S, Trillo Aliaga P, Munzone E, Bagnardi V, Pagan E, Montagna E, Cancello G, Ghisini R, Sangalli C, Negri M, Mazza M, Iorfida M, Cardillo A, Sciandivasci A, Bianco N, De Maio AP, Milano M, Campennì GM, Sansonno L, Viale G, Morra A, Leonardi MC, Galimberti V, Veronesi P, Colleoni M.
Dellapasqua S, et al. Among authors: campenni gm.
Curr Oncol. 2021 Dec 7;28(6):5167-5178. doi: 10.3390/curroncol28060433.
Curr Oncol. 2021.
PMID: 34940072
Free PMC article.
Clinical Trial.